Literature DB >> 24976981

Pulmonary hypertension in end-stage renal disease and post renal transplantation patients.

Esam H Alhamad1, Mohammed Al-Ghonaim1, Hussam F Alfaleh1, Joseph P Cal1, Nazmi Said1.   

Abstract

BACKGROUND: Information regarding lung function parameters and functional capacity in renal failure and post renal transplantation patients with pulmonary hypertension (PH) is limited. The purpose of this study was to examine the clinical characteristics of patients with PH who were receiving hemodialysis (HD) or peritoneal dialysis (PD) or who had undergone renal transplantation.
METHODS: A prospective study was performed on 116 patients (HD =55, PD =17, and post renal transplantation =44) who underwent Doppler echocardiography. PH was defined as systolic pulmonary artery pressure (SPAP) ≥40 mmHg. Demographic information, clinical characteristics, pulmonary function tests (PFTs) and the six-minute walk test (6MWT) were collected and compared between the patients with and without PH.
RESULTS: Twelve (21.8%) patients receiving HD, four (23.5%) patients receiving PD, and eight (18.2%) post renal transplantation patients had PH. In the HD group, the physiological indicators (including pulmonary function test parameters, the final Borg score, and walking distance during the 6MWT) were all significantly lower in the patients with PH compared with those without PH (all P<0.0001). However, in the PD and post renal transplantation groups, no significant differences were noted in the demographic characteristics or in the physiological parameters when the PH patients were compared with those without PH (all P>0.05).
CONCLUSIONS: Among HD patients, marked aberrations in PFT results or walking distance may identify a subset of patients suffering from PH.

Entities:  

Keywords:  Pulmonary hypertension (PH); functional capacity; hemodialysis (HD); lung function; renal failure

Year:  2014        PMID: 24976981      PMCID: PMC4073359          DOI: 10.3978/j.issn.2072-1439.2014.04.29

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  44 in total

1.  Exercise capacity in hemodialysis and renal transplant patients.

Authors:  M A Violan; T Pomes; S Maldonado; G Roura; I De la Fuente; T Verdaguer; R Lloret; J V Torregrosa; J M Campistol
Journal:  Transplant Proc       Date:  2002-02       Impact factor: 1.066

Review 2.  Skeletal muscle dysfunction in chronic renal failure: effects of exercise.

Authors:  Gregory R Adams; Nosratola D Vaziri
Journal:  Am J Physiol Renal Physiol       Date:  2006-04

Review 3.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

Review 4.  Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathogenesis and therapeutic prospective.

Authors:  Zaid Abassi; Farid Nakhoul; Eliyahu Khankin; Shimon A Reisner; Mordechai Yigla
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-07       Impact factor: 2.894

5.  Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease.

Authors:  Christopher W McIntyre; Nicholas M Selby; Mhairi Sigrist; Lyndsay E Pearce; Thomas H Mercer; Patrick F Naish
Journal:  Nephrol Dial Transplant       Date:  2006-02-27       Impact factor: 5.992

6.  Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients.

Authors:  Edith M Simmons; Anthony Langone; M Tugrul Sezer; John P Vella; Peter Recupero; Jason D Morrow; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Transplantation       Date:  2005-04-27       Impact factor: 4.939

7.  Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.

Authors:  Jiangzi Yuan; Qunying Guo; Abdul Rashid Qureshi; Björn Anderstam; Monica Eriksson; Olof Heimbürger; Peter Bárány; Peter Stenvinkel; Bengt Lindholm
Journal:  Nephrol Dial Transplant       Date:  2013-07-04       Impact factor: 5.992

8.  Negative effects of chronic kidney failure on lung function and functional capacity.

Authors:  Juliana L Cury; Antonio F Brunetto; Ricardo D Aydos
Journal:  Rev Bras Fisioter       Date:  2010-05-14

9.  Pulmonary hypertension in patients with chronic renal failure: role of parathyroid hormone and pulmonary artery calcifications.

Authors:  Mona Amin; Ashraf Fawzy; Magdy Abdel Hamid; Abdou Elhendy
Journal:  Chest       Date:  2003-12       Impact factor: 9.410

10.  Pulmonary function in renal transplant recipients and end-stage renal disease patients undergoing maintenance dialysis.

Authors:  O Karacan; E Tutal; T Colak; S Sezer; F O Eyüboğlu; M Haberal
Journal:  Transplant Proc       Date:  2006-03       Impact factor: 1.066

View more
  6 in total

1.  Long-term impacts of hemodialysis on the right ventricle: Assessment via 3-dimensional speckle-tracking echocardiography.

Authors:  Minmin Sun; Xuesen Cao; Yao Guo; Xiao Tan; Lili Dong; Cuizhen Pan; Xianhong Shu
Journal:  Clin Cardiol       Date:  2018-01-24       Impact factor: 2.882

2.  Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension.

Authors:  Michelle C Nguyen; Teresa Po-Yu Chiang; Allan B Massie; Sunjae Bae; Jennifer D Motter; Daniel C Brennan; Niraj M Desai; Dorry L Segev; Jacqueline M Garonzik-Wang
Journal:  Transplant Direct       Date:  2021-07-23

Review 3.  The Role of Thyroid Disorders, Obesity, Diabetes Mellitus and Estrogen Exposure as Potential Modifiers for Pulmonary Hypertension.

Authors:  Eleni Vrigkou; Evangeline Vassilatou; Effrosyni Dima; David Langleben; Anastasia Kotanidou; Marinella Tzanela
Journal:  J Clin Med       Date:  2022-02-10       Impact factor: 4.241

4.  Prevalence of pulmonary hypertension in peritoneal dialysis patients: a meta-analysis.

Authors:  Yuanyuan Li; Weifeng Shang; Qiaofa Lu; Bo Zhang; Yali Ren; Yanbo Sun; Junwu Dong
Journal:  Int Urol Nephrol       Date:  2018-11-19       Impact factor: 2.370

Review 5.  Valvular Heart Disease in Patients with Chronic Kidney Disease.

Authors:  Konstantina Kipourou; Jamie M O'Driscoll; Rajan Sharma
Journal:  Eur Cardiol       Date:  2022-01-31

6.  Risk factors for pulmonary hypertension in patients receiving maintenance peritoneal dialysis.

Authors:  Y Zeng; D D Yang; S Feng; H Y Shen; Z Wang; S Jiang; Y B Shi; J X Fu
Journal:  Braz J Med Biol Res       Date:  2016-02-02       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.